When the “Zone of Life” Encounters a Hemorrhagic Crisis
In the intricately complex human nervous system, the brainstem occupies a small area, with a diameter of only 3 centimeters, yet it bears the crucial responsibility of being the “center of life.” It functions like a tireless commander, continuously regulating core vital signs such as breathing, heartbeat, and blood pressure, ensuring that all organs work in harmony. However, when this critical area experiences a sudden brain hemorrhage, it is akin to a stone being thrown into a calm lake, instantly creating tumultuous waves and leading to extremely severe consequences.
Brainstem hemorrhage accounts for 6%-10% of spontaneous intracerebral hemorrhage cases. Although this percentage may seem small, the mortality rate is as high as 65%, making it one of the most dangerous emergencies in neurosurgery. For instance, a brainstem hemorrhage is like a severe accident occurring at a busy urban traffic hub, causing the entire city’s traffic to come to a standstill, leading to chaos in bodily systems. Patients often rapidly experience loss of consciousness, limb paralysis, and even respiratory and cardiac arrest, putting their lives at great risk.
In the past, traditional craniotomy was the primary method for treating brainstem hemorrhage. However, due to the deep location of the brainstem, surrounded by important nerves and blood vessels, the surgical path is long and complex. Surgeons navigate this treacherous path as if walking on a thorny road, where even a slight misstep could damage normal brain tissue, leading to unpredictable complications. Therefore, traditional surgery is often regarded as a “surgical forbidden zone,” and many doctors find it challenging to treat such patients.
With the rapid advancement of technology, robot-assisted techniques have emerged like a ray of hope, illuminating the difficult path of treating brainstem hemorrhage and bringing new life to patients. With its unique technological advantages, it has broken through many limitations of traditional surgery, opening a new chapter in brainstem hematoma removal. Let us delve into the mysteries and achievements of this remarkable technology.
Brainstem Hemorrhage: The Dilemmas of Traditional Treatment and the Uniqueness of the Life Center
(1) Deadly Threat: The Pathological Mechanism and Clinical Challenges of Brainstem Hemorrhage
The brainstem, a small structure hidden at the base of the brain, is densely packed with numerous nerve nuclei and conduction bundles, functioning like a complex circuit responsible for transmitting nerve signals and maintaining normal physiological functions. When a brainstem hemorrhage occurs, it is akin to these precise circuits experiencing a short circuit, instantly causing severe malfunctions.
Various factors such as hypertension, vascular malformations, and coagulation disorders can act as “triggers” for brainstem hemorrhage. Once bleeding occurs, even a hematoma of just over 5 milliliters can act like a bomb “exploding” within the brainstem, creating a significant mass effect that compresses surrounding fragile nerve tissues, leading to obstructed nerve conduction and a series of life-threatening symptoms. Patients often quickly fall into deep coma, as if swallowed by darkness, with no awareness; their limbs become like puppets without control, exhibiting severe paralysis and inability to move independently; more alarmingly, if the respiratory center is affected, breathing may become weak, rapid, or even stop altogether, with life hanging by a thread.
Faced with the severe challenge of brainstem hemorrhage, traditional craniotomy was once the main treatment method, but it faced numerous dilemmas. Due to the deep location of the brainstem, surrounded by hard skull and complex brain structures, the surgical path is long and winding. To reach the bleeding site, surgeons must navigate through a dark maze, crossing many important nerves and blood vessels. This not only requires surgeons to possess exceptional surgical skills and rich experience but also resembles a fierce gamble with risks and uncertainties. During the surgery, even the slightest touch could trigger a domino effect, leading to a series of severe complications such as permanent paralysis or aphasia due to nerve function damage, or rebleeding caused by ruptured blood vessels. According to relevant clinical data, the disability rate after traditional craniotomy exceeds 70%, meaning that most patients, even if they survive the surgery, will face the harsh reality of lifelong disability, severely diminishing their quality of life. For elderly patients with underlying conditions such as hypertension and diabetes, the surgical risks increase exponentially, as their frail bodies often struggle to withstand the significant trauma caused by surgery, making the postoperative recovery path fraught with thorns.
(2) Limitations of Medical Treatment: The Critical Threshold from Conservative to Interventional Approaches
For patients with mild brainstem hemorrhage of less than 5 milliliters, conservative medical treatment is usually the first choice. Doctors will strictly control the patient’s blood pressure through medication to maintain stable levels and prevent fluctuations that could exacerbate the bleeding; simultaneously, dehydrating agents such as mannitol are used to reduce intracranial pressure, alleviating the compression of the hematoma on surrounding brain tissue, creating conditions for the recovery of nerve function. However, medical treatment is not foolproof, and 30% of patients may experience deterioration during treatment. The hematoma may expand like a balloon, or cerebral edema may worsen, leading to a rise in intracranial pressure, at which point medical treatment can no longer effectively control the condition, forcing patients to undergo surgical treatment, undoubtedly placing immense psychological pressure and financial burden on patients and their families.
When the volume of brainstem hemorrhage reaches 5 milliliters or more, the situation becomes even more critical. A large hematoma acts like a heavy “boulder,” compressing the brainstem and leading to rapid failure of brainstem function. If the hematoma is not promptly removed, the mortality rate for patients will rise exponentially with time. Every minute of delay could bring the patient closer to death. In such cases, traditional medical treatment methods often prove inadequate, failing to fundamentally resolve the issue, creating an urgent need for more effective treatment methods to break this deadlock and save patients’ lives.
Robot-Assisted Technology: Reconstructing the Precision Logic of Brainstem Surgery
(1) Core Technological Advantages: A Disruptive Breakthrough from “Blind Puncture” to “Visual”
Sub-millimeter Precision Positioning: Through three-dimensional CT/MRI imaging reconstruction, the robotic system plans the optimal puncture path, controlling the error within 0.3 millimeters, avoiding dense areas of brainstem nuclei and blood vessels (such as the pyramidal tract and reticular formation).
In traditional brainstem hematoma removal surgeries, surgeons operate as if they are groping in the dark, relying on experience and limited imaging information to determine the surgical path. In such a complex area with intricate distributions of nerves and blood vessels, even a slight deviation could lead to severe consequences. The emergence of robot-assisted technology has completely changed this situation. It acts like a super assistant with “X-ray vision,” using advanced three-dimensional CT/MRI imaging reconstruction technology to clearly present the internal structure of the patient’s brainstem, as if drawing a precise “map.”
Based on this “map,” the robotic system can utilize complex algorithms and intelligent analysis to plan the safest and most efficient puncture path. During this process, it can accurately identify various nuclei and densely packed blood vessel areas within the brainstem, such as the pyramidal tract, which is responsible for transmitting motor commands from the brain and plays a key role in limb movement; and the reticular formation, which is involved in regulating various physiological functions such as sleep and wakefulness. The robot skillfully avoids these critical areas, strictly controlling the puncture error within 0.3 millimeters, significantly reducing surgical risks and improving the success rate of the surgery.
Full-Process Visualization Operation: Combined with contact endoscopic drainage catheters, the surgeon can observe the morphology of the hematoma cavity in real-time, avoiding the blindness of traditional punctures, with suction efficiency increased by 40% and normal tissue damage rate reduced by 65%.
In previous puncture surgeries, surgeons could not intuitively see the internal condition of the hematoma and could only rely on experience and tactile feedback to operate, akin to searching for something in an opaque box, filled with uncertainty and prone to errors that could damage normal brain tissue. The combination of robot-assisted technology and contact endoscopic drainage catheters opens a “window of observation” for surgeons.
During the surgery, the contact endoscopic drainage catheter acts like a miniature camera, entering the hematoma cavity along the puncture path guided by the robot. It can transmit the morphology, size, and surrounding tissue conditions of the hematoma cavity clearly to the surgical monitoring screen in real-time. Surgeons can observe the surgical progress as if watching a high-definition video, accurately judging the location and extent of the hematoma, and performing targeted suction operations. As a result, suction efficiency has significantly improved, increasing by 40% compared to traditional surgeries. Additionally, by clearly distinguishing between normal tissue and the hematoma, surgeons can operate more precisely, avoiding unnecessary damage to normal tissue, with the normal tissue damage rate reduced by 65%, creating favorable conditions for the postoperative recovery of nerve function.
Minimally Invasive Innovation: Only 2 – 3 millimeter bone holes are needed, compared to the 10-centimeter incision of traditional craniotomy, with intraoperative blood loss reduced from an average of 200 milliliters to below 15 milliliters, significantly reducing the risk of postoperative infection and cerebral edema.
Traditional craniotomy requires a long incision of up to 10 centimeters on the patient’s head, akin to opening a “big door” to access the cranial cavity for operation. This not only causes significant trauma to the patient’s scalp and skull but also leads to substantial blood loss, with an average blood loss of up to 200 milliliters. Such extensive trauma increases the difficulty and risks of the surgery, resulting in slow postoperative recovery and a high likelihood of various complications, such as postoperative infections and cerebral edema, severely affecting the patient’s rehabilitation process.
In contrast, robot-assisted brainstem hematoma removal surgery has achieved a minimally invasive innovation, requiring only a tiny 2 – 3 millimeter bone hole in the patient’s head, like opening a “small window.” Through this small hole, robot-assisted instruments can accurately reach the hematoma site for operation. This minimally invasive approach greatly reduces damage to the patient’s body, with intraoperative blood loss significantly decreased, typically controlled below 15 milliliters. The reduction in blood loss not only lowers the risk of shock due to excessive blood loss during surgery but also decreases the risk of postoperative infections, as smaller incisions heal better and reduce the chances of bacterial infections. Additionally, due to less damage to brain tissue, the occurrence of postoperative cerebral edema is significantly reduced, allowing patients to recover faster, shorten hospital stays, lower medical costs, and improve quality of life.
(2) Multimodal Technology Collaboration: The “Intelligent Collaboration” of Robots and Clinical Teams
Preoperative multidisciplinary consultations (neurosurgery, anesthesiology, hematology, etc.) assess surgical tolerance, such as transfusing cold precipitated plasma to patients with thrombocytopenia to correct coagulation; during surgery, the robot accurately locates the hematoma, and the doctor dynamically adjusts the suction pressure based on real-time imaging, achieving a deep integration of “mechanical precision” and “clinical experience.”
The success of robot-assisted brainstem hematoma removal surgery relies on the collaboration of multimodal technologies and the close “intelligent collaboration” between robots and clinical teams. Before the surgery, a comprehensive and detailed multidisciplinary consultation is initiated, gathering neurosurgeons, anesthesiologists, hematologists, and other experts to collectively strategize for the patient’s surgery. They comprehensively assess the patient’s physical condition, including age, underlying diseases, and cardiopulmonary function, with a focus on evaluating the patient’s surgical tolerance.
For example, for patients with thrombocytopenia, hematologists will timely transfuse cold precipitated plasma based on the patient’s specific situation to correct coagulation disorders, ensuring that bleeding does not occur during the surgery due to coagulation issues. Anesthesiologists will develop personalized anesthesia plans based on the patient’s physical condition and surgical needs, ensuring that the patient remains safe and pain-free during the procedure.
As the surgery begins, the robot quickly and accurately locks onto the location of the brainstem hematoma and plans the optimal puncture path. However, the surgery is not a “one-man show” for the robot; the rich clinical experience of the surgeons is equally crucial. After the robot completes the precise positioning, neurosurgeons closely monitor the surgical progress using real-time imaging. They dynamically adjust the suction pressure based on the texture of the hematoma and changes in surrounding tissues. If the hematoma is hard, the surgeon may increase the suction pressure, but must always be cautious to avoid excessive pressure that could damage surrounding normal tissue; if the hematoma is soft, the surgeon will reduce the suction pressure to ensure precision and safety in the operation. This deep integration of “mechanical precision” and “clinical experience” resembles a perfectly coordinated symphony, with each instrument working together to create a successful life-saving melody for the patient, providing strong support for their recovery.
Clinical Evidence: The Effectiveness of Technology from High-Risk Cases
(1) Breakthroughs in Complex Cases: The Life Turnaround of a 71-Year-Old Cirrhotic Patient
In the journey of continuous breakthroughs in medical technology, every successful treatment of a complex case shines like a pearl, illuminating the path of medical advancement. Shanghai Fourth Hospital once welcomed a particularly complex patient—71-year-old Grandma Wang.
Grandma Wang was urgently sent to Shanghai Fourth Hospital due to “sudden consciousness disturbance accompanied by vomiting for 1 hour.” Upon admission, her condition was critical, with a Glasgow Coma Scale (GCS) score of only 4, deeply in a comatose state, showing a straight limb response to painful stimuli. Both pupils were only 2 millimeters in diameter, with sluggish light reflexes. Although her spontaneous breathing was normal and blood pressure temporarily stable, the results of routine blood tests were concerning, with platelet counts far below normal levels. Further diagnosis revealed that Grandma Wang was not only facing the deadly threat of brainstem hemorrhage but also had multiple underlying diseases, including cirrhosis, splenomegaly, thrombocytopenia, grade 3 hypertension (extremely high risk), and pulmonary infection, which undoubtedly complicated the formulation and implementation of subsequent treatment plans, akin to finding a way out in a thicket of thorns.
Faced with such a complex and challenging condition, the neurosurgery team at Shanghai Fourth Hospital responded swiftly, immediately activating a multidisciplinary collaboration mechanism. Experts from anesthesiology, perioperative medicine, hematology, and critical care medicine jointly conducted a comprehensive and in-depth assessment of Grandma Wang’s condition. During preoperative checks, Grandma Wang’s platelet count further declined, sharply increasing the risk of intraoperative and postoperative bleeding. To create conditions for the surgery, the medical team raced against time, urgently transfusing platelets and cold precipitated plasma to stabilize her coagulation function, seizing the opportunity to prepare for surgery.
On September 3, under general anesthesia, Director Zhang Zhiwen led the neurosurgery team to commence this battle against death. They performed “robot-assisted fully visualized brainstem hematoma puncture, suction, and drainage surgery + Ommaya reservoir implantation + intracranial pressure monitoring probe placement.” During the surgery, the robot-assisted system acted as a precise navigator, playing a key role. It utilized advanced technology to achieve sub-millimeter precision in locating the brainstem hematoma and planned the safest and most effective surgical path. Subsequently, the contact endoscopic drainage catheter was slowly sent into the brainstem hematoma cavity along the planned path. During this process, the endoscope on the catheter acted like a guiding light, presenting the operational field in real-time and clearly, allowing the surgeon to operate steadily under close monitoring. Ultimately, 15 milliliters of hematoma were successfully aspirated, and the entire surgical process was completed smoothly without any intraoperative complications.
Postoperative re-examination of the cranial CT yielded encouraging results. The position of Grandma Wang’s intracranial drainage tube was ideal, the brainstem hematoma removal effect was very satisfactory, and there was no bleeding at any of the puncture sites, achieving the expected results perfectly. Even more gratifying was that Grandma Wang’s physical condition gradually improved, with a significant enhancement in her consciousness state, with her GCS score rising from 4 before surgery to 5, showing a flexion response to painful stimuli, and her spontaneous breathing and pupil conditions remained stable. This series of positive changes not only gave Grandma Wang’s family hope but also highlighted the powerful advantages of robot-assisted surgery in handling complex cases. It broke through the limitations of traditional surgery, bringing new life to elderly patients with multiple comorbidities, proving that even in the face of numerous difficulties, modern medical technology can create miracles of life.
(2) A Benchmark for Technological Iteration: Upgrading from “Drainage” to “Removal”
In the long river of technological development for brainstem hematoma treatment, the innovative exploration of Chongqing Xinqiao Hospital shines like a beacon, guiding the direction of technological iteration and upgrading. They innovatively developed the “Tiandi Tong” surgical technique, which fundamentally changed the traditional treatment model and became a key turning point from “drainage” to “removal.”
Traditional brainstem hematoma drainage surgery, while alleviating the pressure of the hematoma on the brainstem to some extent, has significant limitations. Its hematoma clearance rate only reaches 60%-70%, meaning that a considerable portion of the hematoma remains in the patient’s body, continuing to compress nerve tissue and affecting recovery. Moreover, traditional drainage surgery often relies on urokinase thrombolysis, which introduces new risks. Urokinase may cause rebleeding, posing a greater threat to the already fragile life of the patient; at the same time, prolonged use may increase the risk of infection, exacerbating the patient’s condition.
In contrast, the “Tiandi Tong” technique developed by Chongqing Xinqiao Hospital successfully breaks through these dilemmas. This technique utilizes robot-assisted technology to achieve the exquisite operation of dual-tube connection and irrigation. During the surgery, the robot accurately locates the brainstem hematoma and guides two drainage tubes into place. One drainage tube is responsible for injecting irrigation fluid, while the other simultaneously drains, significantly increasing the hematoma clearance rate to over 90%. This remarkable improvement means that more hematomas can be promptly cleared, greatly reducing the pressure on the brainstem nerve tissue and creating extremely favorable conditions for the recovery of nerve function.
Surprisingly, with the increase in hematoma clearance rate and the optimization of treatment methods, the postoperative mortality rate has also significantly decreased, dropping below 25%. Notably, the “Tiandi Tong” technique does not rely on urokinase thrombolysis, fundamentally reducing the risks of rebleeding and infection, making the treatment process safer and more reliable for patients.
This technological innovation and upgrade are particularly prominent when facing diffuse “maple leaf” hematomas. Due to their complex shape and widespread distribution, traditional surgery often struggles to effectively address them, becoming a significant treatment challenge. However, the “Tiandi Tong” technique, with its unique dual-tube irrigation design, can thoroughly clear hematomas from every corner, filling the gap in the indications for traditional surgery in this area. It opens the door of hope for patients who have been “turned away” by traditional surgery, allowing more brainstem hemorrhage patients to receive effective treatment and regain their chance at life. The innovative achievements of Chongqing Xinqiao Hospital not only represent a significant technological breakthrough but also provide strong protection for patients’ lives, injecting new vitality into the field of brainstem hematoma treatment.
Patient Benefits: Dual Improvement from Survival to Quality of Life
(1) Short-Term Efficacy: Rapid Stabilization of Vital Signs and Protection of Nerve Function
In the race against death during brainstem hematoma removal surgery, every second is crucial, and robot-assisted technology undoubtedly provides patients with more precious survival opportunities, bringing immediate short-term efficacy.
Compared to traditional surgery, the advantages of robot-assisted surgery are striking. Within 48 hours post-surgery, the intracranial pressure in the robot-assisted group decreased by as much as 40%. This is akin to releasing air from an over-inflated balloon, effectively alleviating the pressure of the hematoma on the brainstem and creating favorable conditions for the recovery of brainstem function. The rapid decrease in intracranial pressure also significantly reduces the risk of severe complications such as brain herniation due to intracranial hypertension, allowing the patient’s vital signs to stabilize quickly.
Moreover, robot-assisted surgery can shorten the time for spontaneous breathing recovery by 30%. Breathing is one of the basic vital signs of life, and the rapid recovery of spontaneous breathing means that patients can more quickly free themselves from dependence on ventilators, reducing the occurrence of complications such as lung infections and laying a solid foundation for subsequent rehabilitation treatment. This is like finding a safe harbor for a ship tossed in a storm, allowing the patient’s life vessel to sail towards safety once again.
In terms of Glasgow Coma Scale (GCS), the robot-assisted group showed an average daily improvement of 1.2 points. The GCS score is an important indicator for assessing the degree of coma and nerve function, and the increase in score directly reflects the improvement in the patient’s consciousness state and recovery of nerve function. This means that patients can wake up from their comatose state more quickly, gradually regaining their perception and responsiveness to the surrounding environment, and returning to the embrace of family and society.
These improvements in short-term efficacy provide a golden opportunity for patients’ subsequent rehabilitation treatment. During this precious time, patients can begin rehabilitation training earlier, promoting further recovery of nerve function and improving quality of life, laying a solid foundation for long-term prognosis improvement.
(2) Long-Term Prognosis: Decreased Disability Rate and Possibility of Functional Reconstruction
The follow-up data from the Second People’s Hospital of Fujian University of Traditional Chinese Medicine reveals the significant advantages of robot-assisted surgery in patients’ long-term prognosis.
Patients who underwent robot-assisted surgery had a 35% higher one-year survival rate compared to the traditional group. This data shines like a ray of light, illuminating the survival path for patients with brainstem hemorrhage. It indicates that robot-assisted surgery can more effectively clear hematomas, reduce damage to the brainstem, thereby increasing patients’ chances of survival, allowing more patients to continue enjoying the beauty of life.
Even more encouraging is that robot-assisted surgery can reduce the rate of moderate to severe disability from 62% to 38%. This means that more patients can avoid severe disabilities after surgery, maintaining good physical function and self-care abilities. They no longer need to rely on others for long-term care and can return to normal life, realizing their self-worth.
Some patients can achieve independent walking and coordination of limb functions six months post-surgery. This breakthrough allows those who were once thought to be potentially bedridden for life to stand up again, taking firm steps towards a new life. They can walk freely, engage in activities, and enjoy life with their families. This is not only a restoration of physical function but also a tremendous psychological boost, allowing patients to regain confidence and courage in life.
Robot-assisted brainstem hematoma removal surgery has completely broken the previous dilemmas of “difficult to save lives, slow recovery,” bringing dual improvements from survival to quality of life for patients. It not only saves patients’ lives but also allows them to live with dignity and quality, becoming a beacon of hope for patients with brainstem hemorrhage.
References:
1. Clinical Case Analysis of Neurosurgery at Shanghai Fourth Hospital (2023-2025).
2. “White Paper on Clinical Application of Neurosurgical Robots in China (2024).”
3. Multicenter Research Report on “Tiandi Tong” Technology at Chongqing Xinqiao Hospital.
4. Data Summary of the International Brainstem Hemorrhage Treatment Collaboration Group (IBHTC) 2025.